| Primary |
| Immunosuppression |
31.6% |
| Product Used For Unknown Indication |
15.8% |
| Immunosuppressant Drug Therapy |
13.2% |
| Liver Transplant |
10.5% |
| Prophylaxis |
5.3% |
| Renal Transplant |
5.3% |
| Stem Cell Transplant |
5.3% |
| Urinary Tract Infection |
5.3% |
| Fungal Infection |
2.6% |
| Herpes Simplex Hepatitis |
2.6% |
| Latent Tuberculosis |
2.6% |
|
| Drug Level Increased |
20.0% |
| Immunosuppressant Drug Level Increased |
6.7% |
| Lung Infection Pseudomonal |
6.7% |
| Post Transplant Distal Limb Syndrome |
6.7% |
| Renal Failure Chronic |
6.7% |
| Renal Tubular Necrosis |
6.7% |
| Supraventricular Tachycardia |
6.7% |
| Thrombotic Microangiopathy |
6.7% |
| Transaminases Increased |
6.7% |
| Urinary Tract Infection |
6.7% |
| Viraemia |
6.7% |
| Vomiting |
6.7% |
| Weight Increased |
6.7% |
|
| Secondary |
| Prophylaxis Against Transplant Rejection |
20.4% |
| Renal Transplant |
18.0% |
| Immunosuppression |
13.6% |
| Immunosuppressant Drug Therapy |
13.2% |
| Ill-defined Disorder |
9.2% |
| Burkitt's Lymphoma |
4.0% |
| Drug Use For Unknown Indication |
3.2% |
| Hepatitis C |
2.8% |
| Lung Transplant |
2.0% |
| Prophylaxis |
2.0% |
| Graft Versus Host Disease In Skin |
1.6% |
| Liver Transplant |
1.6% |
| Anti-infective Therapy |
1.2% |
| Graft Versus Host Disease |
1.2% |
| Heart And Lung Transplant |
1.2% |
| Respiratory Syncytial Virus Infection |
1.2% |
| Transplant Rejection |
1.2% |
| Convulsion Prophylaxis |
0.8% |
| Gastrooesophageal Reflux Disease |
0.8% |
| Nephrotic Syndrome |
0.8% |
|
| Renal Failure Acute |
8.9% |
| Vomiting |
8.9% |
| Weight Decreased |
8.9% |
| Renal Failure |
6.7% |
| Transplant Rejection |
6.7% |
| Progressive Multifocal Leukoencephalopathy |
4.4% |
| Proteinuria |
4.4% |
| Renal Failure Chronic |
4.4% |
| Renal Impairment |
4.4% |
| Renal Tubular Necrosis |
4.4% |
| Respiratory Syncytial Virus Infection |
4.4% |
| Rhinorrhoea |
4.4% |
| T-cell Lymphoma |
4.4% |
| Thrombotic Microangiopathy |
4.4% |
| Ventricular Fibrillation |
4.4% |
| Walking Aid User |
4.4% |
| White Blood Cell Count Decreased |
4.4% |
| Breast Cancer |
2.2% |
| Clear Cell Carcinoma Of The Kidney |
2.2% |
| Cutaneous Leishmaniasis |
2.2% |
|
| Concomitant |
| Prophylaxis Against Transplant Rejection |
34.3% |
| Renal Transplant |
12.4% |
| Renal And Pancreas Transplant |
7.6% |
| Hepatitis C |
4.8% |
| Anti-infective Therapy |
3.8% |
| Lung Infection |
3.8% |
| Acute Graft Versus Host Disease |
2.9% |
| Chronic Myeloid Leukaemia |
2.9% |
| Cytomegalovirus Infection |
2.9% |
| Ill-defined Disorder |
2.9% |
| Immunosuppression |
2.9% |
| Liver Abscess |
2.9% |
| Transplant Rejection |
2.9% |
| Acute Myeloid Leukaemia |
1.9% |
| Arthritis Bacterial |
1.9% |
| Aspergillosis |
1.9% |
| Bronchopulmonary Aspergillosis |
1.9% |
| Cryoglobulinaemia |
1.9% |
| Drug Use For Unknown Indication |
1.9% |
| Graft Versus Host Disease |
1.9% |
|
| Hyponatraemia |
8.3% |
| Post Procedural Complication |
8.3% |
| Venous Thrombosis |
8.3% |
| Kidney Transplant Rejection |
6.3% |
| Pancreas Transplant Rejection |
6.3% |
| Refusal Of Treatment By Patient |
6.3% |
| Renal Failure Acute |
6.3% |
| Hyperkalaemia |
4.2% |
| Liver Function Test Abnormal |
4.2% |
| Nephropathy Toxic |
4.2% |
| Off Label Use |
4.2% |
| Post Herpetic Neuralgia |
4.2% |
| Pulmonary Tuberculosis |
4.2% |
| Rectal Haemorrhage |
4.2% |
| Sepsis |
4.2% |
| Tachypnoea |
4.2% |
| Transplant Rejection |
4.2% |
| Vomiting |
4.2% |
| Chorioretinopathy |
2.1% |
| Drug Ineffective For Unapproved Indication |
2.1% |
|
